StonvexLoading…
StonvexStonvexStonvexCore line items from AXR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $41.82M | $27.25M | $17.85M | $49.69M |
Operating Income | $10.27M | $7.26M | $6.15M | $12.11M |
Net Income | $9.04M | $5.89M | $4.69M | $12.72M |
EPS (Diluted) | $1.68 | $1.09 | $0.87 | $2.37 |
Total Assets | $143.94M | $140.13M | $140.66M | $133.78M |
Total Liabilities | $4.57M | $4.11M | $5.93M | $3.81M |
Cash & Equivalents | $50.00M | $44.62M | $48.94M | $39.47M |
Free Cash Flow OCF − CapEx | $10.58M | $5.19M | $9.51M | $9.66M |
Shares Outstanding | 5.38M | 5.38M | 5.38M | 5.37M |